Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors

Figure 3

Kaplan-Meier curves of PFS (a) and OS (b) for all 25 patients with HER2-positive nonbreast advanced solid tumors.

(a)

(b)